Glioblastoma progression is hindered by melatonin-primed mesenchymal stromal cells through dynamic intracellular and extracellular reorganizations.

Saved in:

Bibliographic Details
Title:	Glioblastoma progression is hindered by melatonin-primed mesenchymal stromal cells through dynamic intracellular and extracellular reorganizations.
Authors:	Olmedo-Moreno L; Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC-US-UPO-FPS, Seville, Spain., Panadero-Morón C; Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC-US-UPO-FPS, Seville, Spain., Sierra-Párraga JM; Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC-US-UPO-FPS, Seville, Spain., Bueno-Fernández R; Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC-US-UPO-FPS, Seville, Spain., Norton ES; Neurosurgery Department, Mayo Clinic, Jacksonville, FL, USA., Aguilera Y; Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC-US-UPO-FPS, Seville, Spain., Mellado-Damas N; Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC-US-UPO-FPS, Seville, Spain., García-Tárraga P; Cavanilles Institute of Biodiversity and Evolutionary Biology, University of Valencia, Valencia, Spain., Morales-Gallel R; Cavanilles Institute of Biodiversity and Evolutionary Biology, University of Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Antequera-Martínez M; Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC-US-UPO-FPS, Seville, Spain., Durán RV; Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC-US-UPO-FPS, Seville, Spain., Ferrer-Lozano J; Department of Pathology, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Escames G; Biomedical Research Center, Health Sciences Technology Park, University of Granada, 18016 Granada, Spain., García-Verdugo JM; Cavanilles Institute of Biodiversity and Evolutionary Biology, University of Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain., Martin-Montalvo A; Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC-US-UPO-FPS, Seville, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain., Guerrero-Cázares H; Neurosurgery Department, Mayo Clinic, Jacksonville, FL, USA., Capilla-González V; Andalusian Molecular Biology and Regenerative Medicine Centre (CABIMER), CSIC-US-UPO-FPS, Seville, Spain.
Source:	Theranostics [Theranostics] 2025 Feb 10; Vol. 15 (7), pp. 3076-3097. Date of Electronic Publication: 2025 Feb 10 (Print Publication: 2025).
Publication Type:	Journal Article
Journal Info:	Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1838-7640
DOI:	10.7150/thno.104143